Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemospan versus Voluven for prevention of perioperative hypotension in primary hip arthroplasty under spinal anesthesia
2006-002513-12Phase 3Completed
- Sponsor
- Sangart
- Start
- Nov 2006
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypotension comparing Hemospan with Voluven (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2006; status: completed.
02
Drugs
HemospanVolulyte
03
Conditions
hypotension
Beyond the preview
Go deeper on 2006-002513-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002513-12.